Human CCL19 - MIP-3 beta ELISA Kit from ROCKLAND IMMUNOCHEMICALS INC.
Search, find, compare suppliers for Human CCL19 - MIP-3 beta ELISA Kit products.
| Edit | |
|---|---|
| Product Name | Human CCL19 - MIP-3 beta ELISA Kit |
| Description | Specificity: Natural and recombinant human CCL19. There is no detectable cross-reactivity with other relevant proteins. Chemokine(C-C motif) ligand 19(CCL19) is a small cytokine belonging to the CC chemokine family that is also known as EBI1 ligand chemokine(ELC) and macrophage inflammatory protein-3-beta (MIP-3-beta). Using PCR of human-rodent hybrids, the CCL19 gene was map to human chromosome 9p13, and the CCL19 gene is not part of the CC chemokine gene cluster on chromosome 17. The cytokine encoded by this gene may play a role in normal lymphocyte recirculation and homing. It also plays an important role in trafficking of T cells in thymus, and in T cell and B cell migration to secondary lymphoid organs. |
| Size | 1 kit |
| Concentration | n/a |
| Applications | ELISA |
| Other Names | Beta chemokine exodus 3, Beta-chemokine exodus-3, C C chemokine ligand 19, C-C motif chemokine 19, CC chemokine ligand 19, CCL19_HUMAN, Chemokine ligand 19, Chemokine ligand 19, Chemokine CC Motif Ligand 19, CK beta 11, CK beta-11, CKb11, EBI1 ligand chemokine, ELC, Epstein-Barr virus-induced molecule 1 ligand chemokine, Exodus 3, Macrophage inflammatory protein 3 beta, MIP 3 beta, MIP-3-beta, MIP-3B, MIP3 beta, MIP3B, SCYA19, Small inducible cytokine A19, Small-inducible cytokine A19 |
| Gene, Accession, CAS # | CCL19, Gene ID: 6363, NCBI: NP_006265.1, UniProt: Q6IBD6 |
| Catalog # | KOA0264 |
| Price | $589 |
| Order / More Info | Human CCL19 - MIP-3 beta ELISA Kit from ROCKLAND IMMUNOCHEMICALS INC. |
| Product Specific References | n/a |
ROCKLAND IMMUNOCHEMICALS INC.
ROCKLAND IMMUNOCHEMICALS INC.
PO Box 5199
Limerick PA 19468
P: 484-791-3823
P: 800.656.7625
F: 484.369.8654
orders@rockland.com
Technical Support: tech@rockland.com
https://www.rockland.com/
Profile of ROCKLAND IMMUNOCHEMICALS INC.